Benzinga's Zunaid Suleman sat down with Dealmaker co-founder and CEO Rebecca Kacaba at Robinhood Markets' HOOD Summit 2024 to ...

Donald Trump is considering suing CBS, alleging that the network deceptively edited a '60 Minutes' interview with Kamala ...

Analysts have set 12-month price targets for Webster Finl, revealing an average target of $57.62, a high estimate of $63.00, ...

Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance.

Nokia Corp (NYSE: NOK) stock rebounds after disappointing quarterly report, with net sales down 8% to $4.76B. CEO focuses on ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world.

Cantor Fitzgerald analyst initiates coverage on PureCycle Technologies, with an Overweight rating and a price forecast of $14 ...

Gilead Sciences is set to withdraw Trodelvy's accelerated approval for metastatic urothelial cancer following unsatisfactory ...

Tyra Biosciences receives an upgrade from BofA, raising the price target to $31. The upgrade follows promising preclinical ...

Analysts estimate that RBB Bancorp will report an earnings per share (EPS) of $0.38. The market awaits RBB Bancorp's announcement, with hopes high for news of surpassing estimates and providing upbeat ...

Analysts are estimating that Alexandria Real Estate will report an earnings per share (EPS) of $2.37. Alexandria Real Estate bulls will hope to hear the company announce they've not only beaten that ...

Novartis' Kisqali receives a positive recommendation from EMA's CHMP for adjuvant treatment of early breast cancer, showing a ...